Home > Insider Trading > Filing (0001181431-13-003222)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
819050	Vical Inc	VICL	Biological Products, (No Disgnostic Substances) (2836)	930948554

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1198237	Phd P Alain Rolland	10390 Pacific Center Court San Diego CA 92121	Exec Vp, Product Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock $.01 Par Value	Acquisiton	2013-01-11	22,092	$0.01	182,023	No	4	P	Direct
Common Stock $.01 Par Value	Disposition	2013-01-11	1,097	$3.31	180,926	No	4	F	Direct
Common Stock $.01 Par Value	Disposition	2013-01-13	2,370	$3.31	178,556	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	F	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2013-01-11	27,837	$0.00	27,837	$3.31
Common Stock	Nonstatutory Stock Option (right to buy)	Acquisiton	2013-01-11	97,163	$0.00	97,163	$3.31

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
724,837	2014-01-11	2023-01-10	No	4	A	Direct
822,000	2014-01-11	2023-01-10	No	4	A	Direct

Footnotes

Represents shares withheld for taxes upon the release of restricted stock granted on January 11, 2010.
Represents shares withheld for taxes upon the release of restricted stock granted on January 13, 2012.
This balance includes 84,842 of unvested restricted stock units.
The right to exercise the above stock options generally vests 25% on the first anniversary date of the grant, with the remaining rights vesting quarterly over the remaining three years.
Shares were acquired pursuant to a restricted stock grant.